135161-97-6 Usage
General Description
1,3,6-trihydroxy-8-n-butylanthraquinone is a chemical compound with a molecular formula of C22H20O6. It is a derivative of anthraquinone and consists of three hydroxy groups and a butyl substituent. 1,3,6-trihydroxy-8-n-butylanthraquinone is commonly used as a dye intermediate and in the manufacturing of pharmaceuticals. It possesses antioxidant properties and has been studied for its potential anti-cancer and anti-inflammatory activities. Additionally, it has been found to exhibit antimicrobial and antifungal properties. Its unique chemical structure and diverse range of potential pharmacological activities make it an interesting compound for further research and development.
Check Digit Verification of cas no
The CAS Registry Mumber 135161-97-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,5,1,6 and 1 respectively; the second part has 2 digits, 9 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 135161-97:
(8*1)+(7*3)+(6*5)+(5*1)+(4*6)+(3*1)+(2*9)+(1*7)=116
116 % 10 = 6
So 135161-97-6 is a valid CAS Registry Number.
InChI:InChI=1/C18H16O5/c1-2-3-4-9-5-10(19)6-12-15(9)18(23)16-13(17(12)22)7-11(20)8-14(16)21/h5-8,19-21H,2-4H2,1H3
135161-97-6Relevant articles and documents
Synthesis of non-steroidal estrogen receptor antagonists R1128 A, B, C, and D via an oxazoline-promoted iterative ortho-lithiation strategy
Fukuda, Tsutomu,Fukushima, Koichiro,Sanai, Susumu,Iwao, Masatomo
, p. 133 - 135 (2012/03/07)
A concise total synthesis of non-steroidal estrogen receptor antagonists R1128 A-D (1a-1d) has been achieved using iterative ortho-lithiation of 2-(4-methoxyphenyl)-4,4- dimethyloxazoline (3) as the key reaction.
